Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
LISTEN NOWThe Freedom Files Podcast Episode 54: David BahnsenListen Here
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/PBM_Illustration.jpg?itok=0H_Cupjb
Blog

FreedomWorks' Bill of the Month for June 2019: The Prescription Drug Price Transparency Act, H.R. 1035

FreedomWorks is proud to announce that our bill of the month for June 2019 is the Prescription Drug Price Transparency Act, H.R. 1035, sponsored by Rep. Doug Collins (R-Ga.). The Prescription Drug Price Transparency Act would require greater transparency and accountability from pharmacy benefit managers (PBMs). This would lower prices for patients, families, and caregivers across the United States.

06/06/2019
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/FW_Illegal_Pricing_Index_Blog_Photo01.jpg?itok=aAHsKhjn
Issue Analysis

The Illegal Pricing Index

The small area of sanity in our healthcare sector is now under threat, however. A new proposal by the Department of Health and Human Services (HHS), referred to as the International Pricing Index (IPI), would dramatically undermine American leadership in pharmaceutical innovation and risk patient access to life-changing and life-saving treatments.

05/16/2019
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Regulatory_Review_Blog01_3.jpg?itok=YAbWE56O
Blog

Regulatory Action Center Review - March 8, 2019

Welcome to FreedomWorks Foundation’s fifth regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy and the American people by delivering regulatory news straight to FreedomWorks activists. Check back in two weeks for the next edition.

03/08/2019
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Regulatory_Review_Blog01_2.jpg?itok=azQNhHox
Blog

Regulatory Action Center Review - February 22, 2019

Welcome to FreedomWorks Foundation’s fourth regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy and the American people by delivering regulatory news straight to FreedomWorks activists. Check back in two weeks for the next edition.

02/22/2019
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Blog

Support the CREATES Act, H.R. 965 and S. 340

On behalf of our activist community, I urge you to contact your representative and senators and ask them to support the CREATES Act, H.R. 965 and S. 340. Introduced in the House by Reps. David Cicilline (D-R.I.) and Jim Sensenbrenner (R-Wisc.) and in the Senate by Sens. Patrick Leahy (D-Vt.), Chuck Grassley (R-Iowa), Mike Lee (R-Utah), and Amy Klobuchar (D-Minn.), the CREATES Act would lower prescription drug prices by giving competitors greater standing to sue pharmaceutical companies for predatory, monopolistic practices.

02/06/2019
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/cloud_of_euro_socialism.jpg?itok=R_TRz9qo
Blog

FreedomWorks Signs Coalition Letter Opposing HHS Medicare Part B Rule

FreedomWorks signed on to a coalition letter with 54 other conservative, free market advocacy groups to oppose the Department of Health and Human Services' (HHS) proposed international pricing index (IPI). If implemented, this rule would tie drug prices for Medicare Part B recipients to an international model based on the prices in over a dozen European countries.

12/04/2018
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/CREATES%20Money.jpg?itok=chlwQIQy
Blog

CREATES Act Opponents are Direly Wrong

Once in a long while, Congress finds a bipartisan fix for dire issues like prescription drug prices. The CREATES Act is such a solution that would remedy price-hiking loopholes abused by big pharmaceutical companies.

03/07/2018
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/dope.jpg?itok=JuTXft2P
Blog

A Free Market Approach to Prescription Drugs

In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it without imposing price controls.

02/06/2018